

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.55272650 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.48337312 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.87942344 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.87942344 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.67257135 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.67257135 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.67257135 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.67257135 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.67257135 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.67257135 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.52843930 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.52843930 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.51353899 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.49272537 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.37547234 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36660770 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 4.24186095 |
| 18 | detection of bacterium (GO:0016045) | 4.21952990 |
| 19 | detection of other organism (GO:0098543) | 4.18167392 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.16018602 |
| 21 | negative T cell selection (GO:0043383) | 4.01005978 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00457165 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.91677390 |
| 24 | response to interleukin-15 (GO:0070672) | 3.90651949 |
| 25 | cellular extravasation (GO:0045123) | 3.90624135 |
| 26 | mast cell activation involved in immune response (GO:0002279) | 3.89570278 |
| 27 | mast cell degranulation (GO:0043303) | 3.89570278 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.84111443 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.77386708 |
| 30 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.74649189 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.73938328 |
| 32 | neutrophil activation (GO:0042119) | 3.71543285 |
| 33 | mast cell activation (GO:0045576) | 3.65036156 |
| 34 | respiratory burst (GO:0045730) | 3.64456098 |
| 35 | T cell homeostasis (GO:0043029) | 3.56543177 |
| 36 | response to peptidoglycan (GO:0032494) | 3.53634159 |
| 37 | positive regulation of granulocyte differentiation (GO:0030854) | 3.53444289 |
| 38 | V(D)J recombination (GO:0033151) | 3.51161342 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48618725 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.47768781 |
| 41 | T cell selection (GO:0045058) | 3.47760056 |
| 42 | leukocyte degranulation (GO:0043299) | 3.45341731 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.43553468 |
| 44 | myeloid cell activation involved in immune response (GO:0002275) | 3.42537771 |
| 45 | regulation of mast cell degranulation (GO:0043304) | 3.42025308 |
| 46 | positive T cell selection (GO:0043368) | 3.40106405 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.37498137 |
| 48 | thymic T cell selection (GO:0045061) | 3.36331974 |
| 49 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.36304694 |
| 50 | defense response to protozoan (GO:0042832) | 3.34592792 |
| 51 | DNA unwinding involved in DNA replication (GO:0006268) | 3.32825308 |
| 52 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.30912609 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29851367 |
| 54 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.29838985 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.29745888 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 3.29263292 |
| 57 | granulocyte activation (GO:0036230) | 3.28167221 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 3.27011238 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26361405 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23200150 |
| 61 | response to host immune response (GO:0052572) | 3.23200150 |
| 62 | Peyers patch development (GO:0048541) | 3.22307445 |
| 63 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.22307445 |
| 64 | germinal center formation (GO:0002467) | 3.20131303 |
| 65 | T cell migration (GO:0072678) | 3.20116429 |
| 66 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18866496 |
| 67 | detection of external biotic stimulus (GO:0098581) | 3.18340742 |
| 68 | T cell receptor signaling pathway (GO:0050852) | 3.18054225 |
| 69 | regulation of regulatory T cell differentiation (GO:0045589) | 3.17451967 |
| 70 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16402059 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.14609255 |
| 72 | regulation of mast cell activation (GO:0033003) | 3.13808918 |
| 73 | positive regulation of Rap GTPase activity (GO:0032854) | 3.13534531 |
| 74 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.09723006 |
| 75 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.09723006 |
| 76 | ribosomal small subunit assembly (GO:0000028) | 3.08933683 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.08274562 |
| 78 | microglial cell activation (GO:0001774) | 3.07753614 |
| 79 | negative regulation of phagocytosis (GO:0050765) | 3.07355618 |
| 80 | neutrophil mediated immunity (GO:0002446) | 3.07252959 |
| 81 | viral transcription (GO:0019083) | 3.04924186 |
| 82 | natural killer cell differentiation (GO:0001779) | 3.03291026 |
| 83 | response to protozoan (GO:0001562) | 3.02776026 |
| 84 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.02277726 |
| 85 | B cell mediated immunity (GO:0019724) | 2.97900131 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 2.92809704 |
| 87 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91365902 |
| 88 | synaptic vesicle maturation (GO:0016188) | 2.91343166 |
| 89 | lymphocyte homeostasis (GO:0002260) | 2.91143321 |
| 90 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90708211 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.90280783 |
| 92 | leukocyte aggregation (GO:0070486) | 2.90189935 |
| 93 | response to host (GO:0075136) | 2.88840817 |
| 94 | response to host defenses (GO:0052200) | 2.88840817 |
| 95 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88840817 |
| 96 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.88800805 |
| 97 | regulation of Rap GTPase activity (GO:0032317) | 2.88192549 |
| 98 | signal complex assembly (GO:0007172) | 2.87971676 |
| 99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.87584623 |
| 100 | cellular response to type I interferon (GO:0071357) | 2.86985669 |
| 101 | type I interferon signaling pathway (GO:0060337) | 2.86985669 |
| 102 | response to type I interferon (GO:0034340) | 2.86517122 |
| 103 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.86357077 |
| 104 | tolerance induction (GO:0002507) | 2.84932280 |
| 105 | translational termination (GO:0006415) | 2.84774540 |
| 106 | locomotory exploration behavior (GO:0035641) | 2.83424716 |
| 107 | interferon-gamma production (GO:0032609) | 2.82748187 |
| 108 | negative regulation of innate immune response (GO:0045824) | 2.81831202 |
| 109 | regulation of regulated secretory pathway (GO:1903305) | 2.80565075 |
| 110 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.78957961 |
| 111 | negative regulation of RNA splicing (GO:0033119) | 2.77623669 |
| 112 | T cell costimulation (GO:0031295) | 2.76716329 |
| 113 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.76319537 |
| 114 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.75466759 |
| 115 | nucleosome disassembly (GO:0006337) | 2.75418080 |
| 116 | protein-DNA complex disassembly (GO:0032986) | 2.75418080 |
| 117 | lymphocyte costimulation (GO:0031294) | 2.72997243 |
| 118 | negative regulation of histone methylation (GO:0031061) | 2.70282899 |
| 119 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.66418628 |
| 120 | DNA strand elongation (GO:0022616) | 2.64747257 |
| 121 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.63300201 |
| 122 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.63267526 |
| 123 | megakaryocyte development (GO:0035855) | 2.61656266 |
| 124 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.60710158 |
| 125 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.60214247 |
| 126 | leukocyte homeostasis (GO:0001776) | 2.60046655 |
| 127 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.59478025 |
| 128 | ncRNA 3-end processing (GO:0043628) | 2.57393780 |
| 129 | translational elongation (GO:0006414) | 2.54511448 |
| 130 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50609799 |
| 131 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.49158577 |
| 132 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.46918893 |
| 133 | positive regulation of interleukin-2 production (GO:0032743) | 2.46554385 |
| 134 | regulation of ARF protein signal transduction (GO:0032012) | 2.45474672 |
| 135 | mature B cell differentiation (GO:0002335) | 2.43188215 |
| 136 | regulation of defense response to virus by virus (GO:0050690) | 2.42831360 |
| 137 | regulation of ARF GTPase activity (GO:0032312) | 2.41135880 |
| 138 | protein complex disassembly (GO:0043241) | 2.39377788 |
| 139 | adaptation of signaling pathway (GO:0023058) | 2.38864591 |
| 140 | regulation of histone H3-K9 methylation (GO:0051570) | 2.38610341 |
| 141 | cellular protein complex disassembly (GO:0043624) | 2.37745422 |
| 142 | regulation of granulocyte differentiation (GO:0030852) | 2.37429489 |
| 143 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.37285289 |
| 144 | activated T cell proliferation (GO:0050798) | 2.36070979 |
| 145 | positive regulation of lamellipodium assembly (GO:0010592) | 2.35121092 |
| 146 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.34867431 |
| 147 | synaptic vesicle exocytosis (GO:0016079) | 2.33480007 |
| 148 | protein localization to kinetochore (GO:0034501) | 2.33421462 |
| 149 | positive regulation of histone deacetylation (GO:0031065) | 2.32842743 |
| 150 | cellular response to interleukin-4 (GO:0071353) | 2.31490587 |
| 151 | regulation of histone H3-K4 methylation (GO:0051569) | 2.31234061 |
| 152 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.30814954 |
| 153 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.29203012 |
| 154 | ribosomal small subunit biogenesis (GO:0042274) | 2.25216562 |
| 155 | natural killer cell activation (GO:0030101) | 2.25043499 |
| 156 | negative regulation of T cell mediated immunity (GO:0002710) | 2.23363876 |
| 157 | regulation of erythrocyte differentiation (GO:0045646) | 2.22789351 |
| 158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.22273060 |
| 159 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.21561516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.19016952 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.56958105 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66037736 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.58638323 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.29634302 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.01632235 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97857600 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.96435050 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.64371313 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.57130642 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.54204978 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.42547578 |
| 13 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.41556007 |
| 14 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.40489795 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36247733 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.34426176 |
| 17 | * MYB_26560356_Chip-Seq_TH2_Human | 2.29317957 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27706184 |
| 19 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.27235628 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.24992293 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.21166576 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20832022 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.20678170 |
| 24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.18286644 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18035980 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.12960771 |
| 27 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12821374 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09249881 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03447119 |
| 30 | * MYB_26560356_Chip-Seq_TH1_Human | 2.01775594 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01287810 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89921019 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84129610 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.80744013 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80561912 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80090819 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74576678 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71366592 |
| 39 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.70232632 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66133331 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63269026 |
| 42 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.59427769 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59066762 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.58428155 |
| 45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58093251 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57137259 |
| 47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48494335 |
| 48 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.45794695 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44957428 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.44882716 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44169616 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44142770 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43393488 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42689728 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39315140 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38308174 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38259011 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36409867 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35692899 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35118433 |
| 61 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34583589 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31918883 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30517887 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29390379 |
| 65 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29043942 |
| 66 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.28256468 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27883271 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25763769 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24790770 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23569258 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23523920 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23391309 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23251810 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21461120 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21412396 |
| 76 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.21391406 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21288508 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20147020 |
| 79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.20069854 |
| 80 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17331084 |
| 81 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17291390 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16532417 |
| 83 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16321743 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15246332 |
| 85 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.15025806 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14985037 |
| 87 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14782067 |
| 88 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14774575 |
| 89 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.14685214 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14354227 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13509094 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13065798 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12248598 |
| 94 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.11990290 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.11229016 |
| 96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10878146 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10390877 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09790115 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09720284 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08640160 |
| 101 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08587009 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08377920 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.07729394 |
| 104 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06855424 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06098684 |
| 106 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05715962 |
| 107 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05157217 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03148441 |
| 109 | P300_27268052_Chip-Seq_Bcells_Human | 1.02608251 |
| 110 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01862261 |
| 111 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.00439383 |
| 112 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00346234 |
| 113 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99434320 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99026336 |
| 115 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98905824 |
| 116 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.98611933 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97876193 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97607121 |
| 119 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.96741953 |
| 120 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.96360056 |
| 121 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95810360 |
| 122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95339987 |
| 123 | P68_20966046_ChIP-Seq_HELA_Human | 0.94126154 |
| 124 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92696965 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92383772 |
| 126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91162954 |
| 127 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90701601 |
| 128 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.90429232 |
| 129 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90381729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.56735568 |
| 2 | MP0003724_increased_susceptibility_to | 3.54338130 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.12782925 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.08630030 |
| 5 | MP0000685_abnormal_immune_system | 2.80457317 |
| 6 | MP0005671_abnormal_response_to | 2.71756523 |
| 7 | MP0001800_abnormal_humoral_immune | 2.66778219 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.64698938 |
| 9 | MP0002398_abnormal_bone_marrow | 2.61051356 |
| 10 | MP0002822_catalepsy | 2.26587538 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.22217624 |
| 12 | MP0003303_peritoneal_inflammation | 2.20752987 |
| 13 | MP0000703_abnormal_thymus_morphology | 2.19302177 |
| 14 | MP0001790_abnormal_immune_system | 2.18561180 |
| 15 | MP0005387_immune_system_phenotype | 2.18561180 |
| 16 | MP0001819_abnormal_immune_cell | 2.17743579 |
| 17 | MP0002723_abnormal_immune_serum | 2.11642583 |
| 18 | MP0003880_abnormal_central_pattern | 2.10377566 |
| 19 | MP0000716_abnormal_immune_system | 2.09837294 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.09430940 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.07203484 |
| 22 | MP0002722_abnormal_immune_system | 2.01790322 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.01465377 |
| 24 | MP0000689_abnormal_spleen_morphology | 1.99612151 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.96518338 |
| 26 | MP0001873_stomach_inflammation | 1.94614177 |
| 27 | MP0010094_abnormal_chromosome_stability | 1.86001452 |
| 28 | MP0008260_abnormal_autophagy | 1.83169876 |
| 29 | MP0003866_abnormal_defecation | 1.81864648 |
| 30 | MP0002429_abnormal_blood_cell | 1.79725665 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.76872278 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.76784312 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.76784312 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.69762161 |
| 35 | MP0002132_abnormal_respiratory_system | 1.67126792 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.66685612 |
| 37 | MP0004381_abnormal_hair_follicle | 1.66167598 |
| 38 | MP0005025_abnormal_response_to | 1.64825186 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.63400839 |
| 40 | MP0009745_abnormal_behavioral_response | 1.60373663 |
| 41 | MP0009785_altered_susceptibility_to | 1.59421233 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.58242678 |
| 43 | MP0009278_abnormal_bone_marrow | 1.56502709 |
| 44 | MP0003111_abnormal_nucleus_morphology | 1.53132115 |
| 45 | MP0002063_abnormal_learning/memory/cond | 1.51134007 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.49261513 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.48630387 |
| 48 | MP0008569_lethality_at_weaning | 1.48001368 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.47281922 |
| 50 | MP0002064_seizures | 1.46297587 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.45084232 |
| 52 | MP0002405_respiratory_system_inflammati | 1.44151029 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.42000621 |
| 54 | MP0003436_decreased_susceptibility_to | 1.37711743 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.37644967 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.37452028 |
| 57 | MP0008057_abnormal_DNA_replication | 1.37210114 |
| 58 | MP0002006_tumorigenesis | 1.34601777 |
| 59 | MP0003077_abnormal_cell_cycle | 1.29770418 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.29544814 |
| 61 | MP0000490_abnormal_crypts_of | 1.25512202 |
| 62 | MP0002419_abnormal_innate_immunity | 1.24991849 |
| 63 | MP0004510_myositis | 1.20944380 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.18652512 |
| 65 | MP0005310_abnormal_salivary_gland | 1.15483549 |
| 66 | MP0001529_abnormal_vocalization | 1.15439403 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.14055455 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.13345797 |
| 69 | MP0004947_skin_inflammation | 1.12849701 |
| 70 | MP0008469_abnormal_protein_level | 1.12418976 |
| 71 | MP0003787_abnormal_imprinting | 1.11711582 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.11041177 |
| 73 | MP0003693_abnormal_embryo_hatching | 1.09387059 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.08600014 |
| 75 | MP0004811_abnormal_neuron_physiology | 1.08593520 |
| 76 | MP0009046_muscle_twitch | 1.07885799 |
| 77 | MP0000015_abnormal_ear_pigmentation | 1.07791683 |
| 78 | MP0002095_abnormal_skin_pigmentation | 1.06936478 |
| 79 | MP0002736_abnormal_nociception_after | 1.05506028 |
| 80 | MP0002272_abnormal_nervous_system | 1.04713934 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 1.04216549 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 1.03971005 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.03636126 |
| 84 | MP0005409_darkened_coat_color | 1.03370914 |
| 85 | MP0001851_eye_inflammation | 0.99800432 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 0.99159982 |
| 87 | MP0008874_decreased_physiological_sensi | 0.98990458 |
| 88 | MP0005451_abnormal_body_composition | 0.96732433 |
| 89 | MP0001845_abnormal_inflammatory_respons | 0.96331649 |
| 90 | MP0001486_abnormal_startle_reflex | 0.93248214 |
| 91 | MP0009764_decreased_sensitivity_to | 0.92342988 |
| 92 | MP0002735_abnormal_chemical_nociception | 0.91533155 |
| 93 | MP0008877_abnormal_DNA_methylation | 0.91070485 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.90479342 |
| 95 | MP0001970_abnormal_pain_threshold | 0.90169252 |
| 96 | MP0003329_amyloid_beta_deposits | 0.89714692 |
| 97 | MP0004957_abnormal_blastocyst_morpholog | 0.86370356 |
| 98 | MP0004270_analgesia | 0.85624296 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.85221535 |
| 100 | MP0001501_abnormal_sleep_pattern | 0.84605648 |
| 101 | MP0008872_abnormal_physiological_respon | 0.84353810 |
| 102 | MP0000858_altered_metastatic_potential | 0.83972674 |
| 103 | MP0002733_abnormal_thermal_nociception | 0.83549276 |
| 104 | MP0001905_abnormal_dopamine_level | 0.83443719 |
| 105 | MP0003690_abnormal_glial_cell | 0.81515914 |
| 106 | MP0004924_abnormal_behavior | 0.81020121 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.81020121 |
| 108 | MP0003879_abnormal_hair_cell | 0.79982007 |
| 109 | MP0000313_abnormal_cell_death | 0.77947398 |
| 110 | MP0008058_abnormal_DNA_repair | 0.76878037 |
| 111 | MP0010307_abnormal_tumor_latency | 0.76279876 |
| 112 | MP0002933_joint_inflammation | 0.76049667 |
| 113 | MP0001663_abnormal_digestive_system | 0.75362227 |
| 114 | MP0001853_heart_inflammation | 0.74547867 |
| 115 | MP0002083_premature_death | 0.74301075 |
| 116 | MP0006082_CNS_inflammation | 0.74297931 |
| 117 | MP0002928_abnormal_bile_duct | 0.68689261 |
| 118 | MP0003075_altered_response_to | 0.65723200 |
| 119 | MP0003828_pulmonary_edema | 0.65409534 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.60965857 |
| 121 | MP0000604_amyloidosis | 0.60846660 |
| 122 | MP0004130_abnormal_muscle_cell | 0.60376916 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.59615975 |
| 124 | MP0005083_abnormal_biliary_tract | 0.58769308 |
| 125 | MP0009763_increased_sensitivity_to | 0.58218243 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.57469512 |
| 127 | MP0001348_abnormal_lacrimal_gland | 0.57321745 |
| 128 | MP0005535_abnormal_body_temperature | 0.55594495 |
| 129 | MP0005166_decreased_susceptibility_to | 0.54878599 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.53861712 |
| 131 | MP0002009_preneoplasia | 0.52984163 |
| 132 | MP0004883_abnormal_blood_vessel | 0.52735494 |
| 133 | MP0003045_fibrosis | 0.51382523 |
| 134 | MP0006035_abnormal_mitochondrial_morpho | 0.49769673 |
| 135 | MP0005058_abnormal_lysosome_morphology | 0.48730906 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.48461633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Panhypogammaglobulinemia (HP:0003139) | 4.77351079 |
| 2 | Chronic otitis media (HP:0000389) | 4.60749566 |
| 3 | Agammaglobulinemia (HP:0004432) | 4.55471981 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.35657700 |
| 5 | B lymphocytopenia (HP:0010976) | 4.07267658 |
| 6 | Abnormality of B cell number (HP:0010975) | 4.07267658 |
| 7 | Recurrent viral infections (HP:0004429) | 4.06759128 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.04163858 |
| 9 | Orchitis (HP:0100796) | 4.03435816 |
| 10 | Optic neuritis (HP:0100653) | 3.92517586 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.92517586 |
| 12 | Cellulitis (HP:0100658) | 3.87819828 |
| 13 | Papilloma (HP:0012740) | 3.82503945 |
| 14 | Verrucae (HP:0200043) | 3.82503945 |
| 15 | IgM deficiency (HP:0002850) | 3.78270900 |
| 16 | T lymphocytopenia (HP:0005403) | 3.77899050 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76438998 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.60786841 |
| 19 | Thyroiditis (HP:0100646) | 3.54461690 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.50131993 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.49237713 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.42820148 |
| 23 | Meningitis (HP:0001287) | 3.42470303 |
| 24 | Abnormality of T cells (HP:0002843) | 3.23595455 |
| 25 | Papilledema (HP:0001085) | 3.17804290 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 3.13532085 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.12371713 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.12371713 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.12134564 |
| 30 | Severe combined immunodeficiency (HP:0004430) | 3.09323055 |
| 31 | Chronic sinusitis (HP:0011109) | 3.03014208 |
| 32 | Hypochromic anemia (HP:0001931) | 3.02650830 |
| 33 | Urticaria (HP:0001025) | 3.02226895 |
| 34 | Inflammation of the large intestine (HP:0002037) | 3.01122828 |
| 35 | Hypochromic microcytic anemia (HP:0004840) | 3.00356747 |
| 36 | Acute lymphatic leukemia (HP:0006721) | 2.99539188 |
| 37 | Increased IgM level (HP:0003496) | 2.97029653 |
| 38 | Abnormality of the fingertips (HP:0001211) | 2.89769270 |
| 39 | Combined immunodeficiency (HP:0005387) | 2.84405986 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84320672 |
| 41 | Nasal polyposis (HP:0100582) | 2.83815606 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.79371795 |
| 43 | Epistaxis (HP:0000421) | 2.77404314 |
| 44 | Colitis (HP:0002583) | 2.75007650 |
| 45 | IgG deficiency (HP:0004315) | 2.72795885 |
| 46 | Episodic fever (HP:0001954) | 2.72064613 |
| 47 | Myokymia (HP:0002411) | 2.70484204 |
| 48 | Abnormal number of erythroid precursors (HP:0012131) | 2.66988312 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.66413311 |
| 50 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.66262005 |
| 51 | Hyperacusis (HP:0010780) | 2.65838607 |
| 52 | Thrombocytosis (HP:0001894) | 2.65733237 |
| 53 | Basal cell carcinoma (HP:0002671) | 2.62542763 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.59059883 |
| 55 | Gingivitis (HP:0000230) | 2.58433351 |
| 56 | Lymphopenia (HP:0001888) | 2.55736300 |
| 57 | Hemoptysis (HP:0002105) | 2.54812203 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.51536198 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.48839178 |
| 60 | Increased IgE level (HP:0003212) | 2.46145380 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.41610008 |
| 62 | Visual hallucinations (HP:0002367) | 2.34747057 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.31564898 |
| 64 | Hypoplasia of the thymus (HP:0000778) | 2.29058197 |
| 65 | Pulmonary embolism (HP:0002204) | 2.27503738 |
| 66 | Autoimmune hemolytic anemia (HP:0001890) | 2.27277552 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.27200664 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 2.26124482 |
| 69 | Focal motor seizures (HP:0011153) | 2.25348105 |
| 70 | Gingival bleeding (HP:0000225) | 2.24802516 |
| 71 | Hypergammaglobulinemia (HP:0010702) | 2.24223380 |
| 72 | Myositis (HP:0100614) | 2.22620821 |
| 73 | Insomnia (HP:0100785) | 2.21570851 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21165593 |
| 75 | Poikiloderma (HP:0001029) | 2.20616786 |
| 76 | Lymphoma (HP:0002665) | 2.19950558 |
| 77 | Recurrent abscess formation (HP:0002722) | 2.18802561 |
| 78 | Arterial thrombosis (HP:0004420) | 2.16474564 |
| 79 | Sepsis (HP:0100806) | 2.15274864 |
| 80 | Anorexia (HP:0002039) | 2.15074739 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.14231640 |
| 82 | Viral hepatitis (HP:0006562) | 2.13025829 |
| 83 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.10811102 |
| 84 | Supranuclear gaze palsy (HP:0000605) | 2.10053270 |
| 85 | Eosinophilia (HP:0001880) | 2.09680995 |
| 86 | Pointed chin (HP:0000307) | 2.09451034 |
| 87 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.09292218 |
| 88 | Bronchitis (HP:0012387) | 2.09035228 |
| 89 | Microcytic anemia (HP:0001935) | 2.08611556 |
| 90 | Abnormality of eosinophils (HP:0001879) | 2.05793235 |
| 91 | Mediastinal lymphadenopathy (HP:0100721) | 2.04456185 |
| 92 | Focal seizures (HP:0007359) | 2.03518204 |
| 93 | Recurrent skin infections (HP:0001581) | 2.03500033 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03477322 |
| 95 | Obstructive lung disease (HP:0006536) | 2.03477322 |
| 96 | Eczematoid dermatitis (HP:0000976) | 1.99891432 |
| 97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98988839 |
| 98 | Stomatitis (HP:0010280) | 1.98769697 |
| 99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97661086 |
| 100 | Abnormality of the pleura (HP:0002103) | 1.97174888 |
| 101 | Skin rash (HP:0000988) | 1.95133228 |
| 102 | Osteomyelitis (HP:0002754) | 1.95047717 |
| 103 | Vasculitis (HP:0002633) | 1.95019710 |
| 104 | Acute hepatic failure (HP:0006554) | 1.93579816 |
| 105 | Chest pain (HP:0100749) | 1.93223776 |
| 106 | Urinary urgency (HP:0000012) | 1.92552346 |
| 107 | Granulocytopenia (HP:0001913) | 1.91888550 |
| 108 | Abnormality of oral frenula (HP:0000190) | 1.90535585 |
| 109 | Reticulocytopenia (HP:0001896) | 1.88480546 |
| 110 | Recurrent bacterial skin infections (HP:0005406) | 1.88464802 |
| 111 | Abnormality of binocular vision (HP:0011514) | 1.87915432 |
| 112 | Diplopia (HP:0000651) | 1.87915432 |
| 113 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85530601 |
| 114 | Increased cerebral lipofuscin (HP:0011813) | 1.85333837 |
| 115 | Annular pancreas (HP:0001734) | 1.85320094 |
| 116 | Impaired smooth pursuit (HP:0007772) | 1.84735077 |
| 117 | Truncal ataxia (HP:0002078) | 1.82730625 |
| 118 | Emphysema (HP:0002097) | 1.82645777 |
| 119 | Purpura (HP:0000979) | 1.81359277 |
| 120 | Petechiae (HP:0000967) | 1.81301713 |
| 121 | Recurrent otitis media (HP:0000403) | 1.80953925 |
| 122 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80840720 |
| 123 | Hypertensive crisis (HP:0100735) | 1.80268976 |
| 124 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79237514 |
| 125 | Amaurosis fugax (HP:0100576) | 1.78446892 |
| 126 | Poor eye contact (HP:0000817) | 1.78005602 |
| 127 | Skin ulcer (HP:0200042) | 1.77659751 |
| 128 | Encephalitis (HP:0002383) | 1.77538456 |
| 129 | IgA deficiency (HP:0002720) | 1.76936893 |
| 130 | Prominent nose (HP:0000448) | 1.72518425 |
| 131 | Vertebral arch anomaly (HP:0008438) | 1.71921236 |
| 132 | Stereotypic behavior (HP:0000733) | 1.71906984 |
| 133 | Spastic gait (HP:0002064) | 1.70233195 |
| 134 | Abnormality of DNA repair (HP:0003254) | 1.69473702 |
| 135 | Leukocytosis (HP:0001974) | 1.69445401 |
| 136 | Hemiplegia (HP:0002301) | 1.68403121 |
| 137 | Ankle clonus (HP:0011448) | 1.67194593 |
| 138 | Large eyes (HP:0001090) | 1.64627319 |
| 139 | Cutaneous melanoma (HP:0012056) | 1.64483377 |
| 140 | Myelodysplasia (HP:0002863) | 1.64280564 |
| 141 | Pustule (HP:0200039) | 1.63638936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.76719636 |
| 2 | EEF2K | 4.15816833 |
| 3 | MAP3K10 | 3.65868062 |
| 4 | SIK2 | 2.75913757 |
| 5 | PRPF4B | 2.67329086 |
| 6 | GRK6 | 2.64756280 |
| 7 | FES | 2.50662775 |
| 8 | ERN1 | 2.44004123 |
| 9 | SYK | 2.06834366 |
| 10 | RIPK4 | 1.96398186 |
| 11 | TAOK3 | 1.95134853 |
| 12 | PKN2 | 1.85204107 |
| 13 | MAP3K13 | 1.74390047 |
| 14 | BTK | 1.72840033 |
| 15 | CDK19 | 1.70852052 |
| 16 | TXK | 1.70224317 |
| 17 | KIT | 1.62746123 |
| 18 | TNK2 | 1.61810031 |
| 19 | CLK1 | 1.58010233 |
| 20 | ZAP70 | 1.48519406 |
| 21 | JAK3 | 1.46263556 |
| 22 | EPHA4 | 1.46076681 |
| 23 | MAP3K9 | 1.45891634 |
| 24 | CDC7 | 1.41769454 |
| 25 | NEK2 | 1.37497591 |
| 26 | TAOK1 | 1.34635054 |
| 27 | CSF1R | 1.32456578 |
| 28 | DAPK1 | 1.32111350 |
| 29 | HCK | 1.31885665 |
| 30 | TRIB3 | 1.30467712 |
| 31 | SCYL2 | 1.27595272 |
| 32 | STK10 | 1.27390728 |
| 33 | MAP3K14 | 1.22801267 |
| 34 | NTRK2 | 1.21507949 |
| 35 | TYK2 | 1.21260865 |
| 36 | ITK | 1.20937636 |
| 37 | MARK2 | 1.20044281 |
| 38 | TESK2 | 1.19251385 |
| 39 | ALK | 1.17145149 |
| 40 | FGR | 1.13624469 |
| 41 | PRKCH | 1.13493149 |
| 42 | MAP3K7 | 1.11643680 |
| 43 | LCK | 1.11221302 |
| 44 | BLK | 1.10862365 |
| 45 | MARK3 | 1.10388790 |
| 46 | LRRK2 | 1.06215313 |
| 47 | IKBKE | 1.05506164 |
| 48 | NTRK3 | 1.03717689 |
| 49 | BMPR2 | 1.01056334 |
| 50 | MAP3K1 | 0.96209380 |
| 51 | UHMK1 | 0.95806958 |
| 52 | RAF1 | 0.94521572 |
| 53 | CAMKK1 | 0.94015476 |
| 54 | CDK4 | 0.93986362 |
| 55 | TNIK | 0.92541469 |
| 56 | SMG1 | 0.91063471 |
| 57 | MINK1 | 0.90752113 |
| 58 | MAP3K12 | 0.89972221 |
| 59 | DAPK2 | 0.89295153 |
| 60 | TEC | 0.87542218 |
| 61 | RPS6KB2 | 0.87191866 |
| 62 | IKBKB | 0.84649708 |
| 63 | KSR2 | 0.82965773 |
| 64 | PRKD2 | 0.80326284 |
| 65 | LYN | 0.79846888 |
| 66 | HIPK2 | 0.79557166 |
| 67 | MAP3K4 | 0.76180675 |
| 68 | CAMKK2 | 0.74087632 |
| 69 | TBK1 | 0.70887108 |
| 70 | BRSK1 | 0.70633565 |
| 71 | CDK5 | 0.69740437 |
| 72 | PDK1 | 0.68722122 |
| 73 | JAK1 | 0.68290542 |
| 74 | PDPK1 | 0.66864235 |
| 75 | TAOK2 | 0.66123888 |
| 76 | CDK12 | 0.65016833 |
| 77 | MAPK13 | 0.64129909 |
| 78 | MAPK4 | 0.63865595 |
| 79 | MARK1 | 0.63512786 |
| 80 | PIM1 | 0.60722277 |
| 81 | MAP3K3 | 0.60418817 |
| 82 | FLT3 | 0.59942573 |
| 83 | CAMK1 | 0.58583496 |
| 84 | STK11 | 0.57263902 |
| 85 | CDK11A | 0.56655533 |
| 86 | CCNB1 | 0.56403527 |
| 87 | MAPK11 | 0.55862124 |
| 88 | CDK15 | 0.54793839 |
| 89 | TYRO3 | 0.54156024 |
| 90 | YES1 | 0.54055346 |
| 91 | PRKCQ | 0.52693007 |
| 92 | CDK18 | 0.52205802 |
| 93 | ATR | 0.51688597 |
| 94 | MAPK12 | 0.51502601 |
| 95 | SIK1 | 0.51259270 |
| 96 | PAK6 | 0.51250644 |
| 97 | JAK2 | 0.51099829 |
| 98 | MAPK7 | 0.50835676 |
| 99 | MAP2K4 | 0.50692123 |
| 100 | SIK3 | 0.50324345 |
| 101 | PTK6 | 0.49060732 |
| 102 | PTK2B | 0.48946825 |
| 103 | MAP3K11 | 0.47932281 |
| 104 | FYN | 0.46237812 |
| 105 | RET | 0.44835958 |
| 106 | MAP3K6 | 0.44160692 |
| 107 | CSK | 0.42949928 |
| 108 | IRAK2 | 0.40392612 |
| 109 | DYRK1B | 0.40197681 |
| 110 | IRAK1 | 0.40055845 |
| 111 | MATK | 0.39625906 |
| 112 | CAMK4 | 0.39575279 |
| 113 | CDK14 | 0.39522795 |
| 114 | PASK | 0.38695691 |
| 115 | PRKCZ | 0.38400393 |
| 116 | CDC42BPA | 0.37958658 |
| 117 | RPS6KL1 | 0.37703922 |
| 118 | RPS6KC1 | 0.37703922 |
| 119 | STK4 | 0.37011743 |
| 120 | CDK2 | 0.34330456 |
| 121 | CHEK1 | 0.34268587 |
| 122 | MAP3K8 | 0.34003724 |
| 123 | MAP2K6 | 0.33926690 |
| 124 | RPS6KA6 | 0.33750953 |
| 125 | FGFR3 | 0.32381238 |
| 126 | EPHB1 | 0.32039340 |
| 127 | IRAK4 | 0.31864912 |
| 128 | BRD4 | 0.31838723 |
| 129 | MAP2K2 | 0.31505649 |
| 130 | MAP2K3 | 0.29634125 |
| 131 | ICK | 0.29564104 |
| 132 | NLK | 0.29256925 |
| 133 | KSR1 | 0.29159896 |
| 134 | RPS6KA2 | 0.28517393 |
| 135 | SGK3 | 0.28406611 |
| 136 | FGFR4 | 0.27368814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.87278173 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.62480648 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53324847 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.50461844 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.44286257 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.01828128 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.99762745 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91924485 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84617853 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80607287 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.77266453 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 1.69842456 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.55767964 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.55749629 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49964504 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.48615370 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.45465900 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42128401 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.40781577 |
| 20 | Ribosome_Homo sapiens_hsa03010 | 1.32493462 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.28347434 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25909173 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25255707 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25240116 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24956081 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.22754502 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21863273 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20282661 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18307426 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17816345 |
| 31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.17765094 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.16645584 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16016987 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.13383895 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.10577869 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.10556684 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10326642 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07297652 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07188306 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05338994 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.05329125 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.05293600 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04103185 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.02188837 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.00612915 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00524586 |
| 47 | Colorectal cancer_Homo sapiens_hsa05210 | 0.99210571 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99075889 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.98863012 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97345882 |
| 51 | Malaria_Homo sapiens_hsa05144 | 0.97234936 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96659506 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.95755344 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94701569 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94027089 |
| 56 | Homologous recombination_Homo sapiens_hsa03440 | 0.92193388 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.91857173 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.91507294 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90522024 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89565905 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89154527 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.88912390 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.88651562 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88516421 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87636396 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86374305 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86066475 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85466605 |
| 69 | Cell cycle_Homo sapiens_hsa04110 | 0.85271762 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.85185349 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84977221 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 0.84933397 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84759780 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83968736 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.83964556 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82644967 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81249272 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79215606 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.79171098 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79113652 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.79104552 |
| 82 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78991456 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76405143 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75673294 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75626877 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74688345 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74353704 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73974258 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72585702 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71836189 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.71082743 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.70992068 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70610427 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68481899 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68355716 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67992119 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.67687956 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66967178 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.66457559 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66060768 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65931066 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65773867 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64373607 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.63119886 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62922558 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62243363 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.62075955 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61740722 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61639197 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60923733 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60794940 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60634788 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60374379 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.59351746 |
| 115 | Allograft rejection_Homo sapiens_hsa05330 | 0.58447801 |
| 116 | Gap junction_Homo sapiens_hsa04540 | 0.57011359 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56604388 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56478757 |
| 119 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56269600 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56217494 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.55551418 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55206960 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54800039 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54502828 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48339450 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46388955 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45445275 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41835539 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40314027 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.39984518 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39337185 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39112208 |
| 133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38424032 |

